475
Views
68
CrossRef citations to date
0
Altmetric
Review

Drugdrug interactions involving membrane transporters in the human kidney

, &
Pages 505-532 | Published online: 21 Jul 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

David J. Wagner, Haichuan Duan, Alenka Chapron, Richard W. Lee & Joanne Wang. (2017) Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids. Xenobiotica 47:12, pages 1112-1120.
Read now
Margherita Strolin Benedetti, Rhys Whomsley, Italo Poggesi, Willi Cawello, François-Xavier Mathy, Marie-Laure Delporte, Peggy Papeleu & Jean-Baptiste Watelet. (2009) Drug metabolism and pharmacokinetics. Drug Metabolism Reviews 41:3, pages 344-390.
Read now
Norma Jung & Dirk Taubert. (2009) Organic cation transporters and their roles in antiretroviral drug disposition. Expert Opinion on Drug Metabolism & Toxicology 5:7, pages 773-787.
Read now
A.J. Scheen. (2008) MEDICATIONS IN THE KIDNEY. Acta Clinica Belgica 63:2, pages 76-80.
Read now
Sarah M Robertson, Scott R Penzak & Alice Pau. (2007) Drug interactions in the management of HIV infection: an update. Expert Opinion on Pharmacotherapy 8:17, pages 2947-2963.
Read now

Articles from other publishers (63)

Joanne L. Parker, Takafumi Kato, Gabriel Kuteyi, Oleg Sitsel & Simon Newstead. (2023) Molecular basis for selective uptake and elimination of organic anions in the kidney by OAT1. Nature Structural & Molecular Biology 30:11, pages 1786-1793.
Crossref
Joanna Łapczuk-Romańska, Maria Droździk, Stefan Oswald & Marek Droździk. (2023) Kidney Drug Transporters in Pharmacotherapy. International Journal of Molecular Sciences 24:3, pages 2856.
Crossref
Antonio J. López Quiñones, Letícia Salvador Vieira & Joanne Wang. (2022) Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta -Iodobenzylguanidine . Drug Metabolism and Disposition 50:9, pages 1218-1227.
Crossref
Phetcharawan Lye, Enrrico Bloise, Guinever E. Imperio, David Chitayat & Stephen G. Matthews. (2022) Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells. Cells 11:14, pages 2259.
Crossref
Manthena V. S. Varma, Ayman El‐Kattan & Yurong Lai. 2022. Drug Transporters. Drug Transporters 433 452 .
Abdulaziz Ahmed A. Saad, Fan Zhang, Eyad Abdulwhab H. Mohammed & Xin’an Wu. (2022) Clinical Aspects of Drug–Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K). Biological and Pharmaceutical Bulletin 45:4, pages 382-393.
Crossref
Lei Zhang, Osatohanmwen J. Enogieru, Sook Wah Yee, Shiew-Mei Huang & Kathleen M. Giacomini. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology 213 239 .
Hong Yang & Yan Shu. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery 193 230 .
Azusa Futatsugi, Yusuke Masuo & Yukio Kato. (2021) Effects of Probenecid on Hepatic and Renal Disposition of Hexadecanedioate, an Endogenous Substrate of Organic Anion Transporting Polypeptide 1B in Rats. Journal of Pharmaceutical Sciences 110:5, pages 2274-2284.
Crossref
Ling Zou, Pär Matsson, Adrian Stecula, Huy X. Ngo, Arik A. Zur & Kathleen M. Giacomini. (2021) Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3. Journal of Pharmaceutical Sciences 110:1, pages 347-353.
Crossref
Siva Nageswara Rao Gajula, Gangireddy Navitha Reddy, Dannarm Srinivas Reddy & Rajesh Sonti. (2020) Pharmacokinetic drug–drug interactions: an insight into recent US FDA-approved drugs for prostate cancer. Bioanalysis 12:22, pages 1647-1664.
Crossref
Christer Rimmler, Christian Lanckohr, Ceren Akamp, Dagmar Horn, Manfred Fobker, Karsten Wiebe, Bassam Redwan, Bjoern Ellger, Robin Koeck & Georg Hempel. (2019) Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis. British Journal of Clinical Pharmacology 85:12, pages 2864-2877.
Crossref
Xiaodong Liu. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity 241 291 .
Elisa Lozano, Oscar Briz, Rocio Macias, Maria Serrano, Jose Marin & Elisa Herraez. (2018) Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition. Journal of Personalized Medicine 8:2, pages 14.
Crossref
Darren Michael Moss, Marco Siccardi & Catia Marzolini. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions 49 85 .
Sumathy Mathialagan, A. David Rodrigues & Bo Feng. (2017) Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine. Journal of Pharmaceutical Sciences 106:9, pages 2535-2541.
Crossref
Xiaoyan Chu, Grace Hoyee Chan & Raymond Evers. (2017) Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions. Journal of Pharmaceutical Sciences 106:9, pages 2357-2367.
Crossref
Manthena V. Varma, Yurong Lai & Ayman F. El-Kattan. (2017) Molecular properties associated with transporter-mediated drug disposition. Advanced Drug Delivery Reviews 116, pages 92-99.
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment 77 138 .
Jia Yin, Haichuan Duan & Joanne Wang. (2016) Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation. Journal of Pharmacology and Experimental Therapeutics 359:3, pages 401-410.
Crossref
Jia Yin & Joanne Wang. (2016) Renal drug transporters and their significance in drug–drug interactions. Acta Pharmaceutica Sinica B 6:5, pages 363-373.
Crossref
Bo Feng & Manthena V. Varma. (2016) Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions. The Journal of Clinical Pharmacology 56, pages S110-S121.
Crossref
Yoshikazu Abe, Yuki Nakano, Toru Kanazawa, Takao Furihata, Takuro Endo & Mamoru Kobayashi. (2016) Investigation of Drug-Drug Interactions Between Ritobegron, a Selective ? 3 -Adrenoceptor Agonist, With Probenecid in Healthy Men . Clinical Pharmacology in Drug Development 5:3, pages 201-207.
Crossref
Ivan Sabolić, Davorka Breljak & Tvrtko Smital. 2016. Organic Cation Transporters. Organic Cation Transporters 217 242 .
Kevin M. Koch, Deborah A. Smith, Jeff Botbyl, Nikita Arya, Linda P. Briley, Leanne Cartee, Jane Holshouser White, Jennifer Beyer, Mohammed M. Dar, Hyun Choel Chung, Quincy Chu & Yung-Jue Bang. (2015) Effect of lapatinib on oral digoxin absorption in patients. Clinical Pharmacology in Drug Development 4:6, pages 449-453.
Crossref
Ayman El‐Kattan, Manthena V. Varma & Yurong Lai. 2014. Drug Transporters. Drug Transporters 371 387 .
Tsuyoshi Mikkaichi, Yasushi Yoshigae, Hiroshi Masumoto, Tomoki Imaoka, Veronika Rozehnal, Thomas Fischer, Noriko Okudaira & Takashi Izumi. (2014) Edoxaban Transport via P-Glycoprotein Is a Key Factor for the Drug’s Disposition. Drug Metabolism and Disposition 42:4, pages 520-528.
Crossref
Annett Kunze, Jörg Huwyler, Birk Poller, Heike Gutmann & Gian Camenisch. (2014) In Vitro–In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs. Journal of Pharmaceutical Sciences 103:3, pages 994-1001.
Crossref
Sreeraj Macha, R?diger Koenen, Regina Sennewald, Katja Sch?ne, Noemi Hummel, Stephan Riedmaier, Hans J. Woerle, Afshin Salsali & Uli C. Broedl. (2014) Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers. Clinical Therapeutics 36:2, pages 280-290.e1.
Crossref
Ryota Kikuchi, Yanbin Lao, Daniel A.J. Bow, William J. Chiou, Mark E. Andracki, Robert A. Carr, Richard L. Voorman & Sonia M. De Morais. (2013) Prediction of Clinical Drug–Drug Interactions of Veliparib (ABT-888) with Human Renal Transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K). Journal of Pharmaceutical Sciences 102:12, pages 4426-4432.
Crossref
Peter Krajcsi. (2013) Drug-transporter interaction testing in drug discovery and development. World Journal of Pharmacology 2:1, pages 35.
Crossref
Pär Matsson, Kathleen M. Giacomini & D. Craig Brater. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney 3185 3214 .
Lei Zhang & Shiew-Mei Huang. 2013. Transporters in Drug Development. Transporters in Drug Development 257 283 .
S Ito, H Kusuhara, Y Kumagai, Y Moriyama, K Inoue, T Kondo, H Nakayama, S Horita, K Tanabe, H Yuasa & Y Sugiyama. (2012) N-Methylnicotinamide Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving Multidrug and Toxin Extrusions (MATE1 and MATE2-K). Clinical Pharmacology & Therapeutics 92:5, pages 635-641.
Crossref
Gerhard Burckhardt. (2012) Drug transport by Organic Anion Transporters (OATs). Pharmacology & Therapeutics 136:1, pages 106-130.
Crossref
Jiwen (Jim) Liu, TaeWeon Lee & Ralph A. DeFronzo. (2012) Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?. Diabetes 61:9, pages 2199-2204.
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design 103 110 .
M. J. Cutler, B. L. Urquhart, T. J. Velenosi, H. E. Meyer zu Schwabedissen, G. K. Dresser, B. F. Leake, R. G. Tirona, R. B. Kim & D. J. Freeman. (2013) In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna. The Journal of Clinical Pharmacology 52:4, pages 530-542.
Crossref
Joseph A. Ware, Lei Zhang & Shiew-Mei Huang. 2012. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology 217 237 .
Douglas B. Kell, Paul D. Dobson & Stephen G. Oliver. (2011) Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discovery Today 16:15-16, pages 704-714.
Crossref
Jiwen (Jim) Liu & TaeWeon Lee. 2011. 103 115 .
Gerhard Burckhardt & Birgitta Christina Burckhardt. 2011. Drug Transporters. Drug Transporters 29 104 .
Catia Marzolini, Manuel Battegay & David Back. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases 43 72 .
Thomas N. Thompson. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development 285 313 .
Yurong Lai, Kathleen E. Sampson, Larissa M. Balogh, Timothy G. Brayman, Steven R. Cox, Wade J. Adams, Vikas Kumar & Jeffrey C. Stevens. (2010) Preclinical and Clinical Evidence for the Collaborative Transport and Renal Secretion of an Oxazolidinone Antibiotic by Organic Anion Transporter 3 (OAT3/SLC22A8) and Multidrug and Toxin Extrusion Protein 1 (MATE1/SLC47A1). Journal of Pharmacology and Experimental Therapeutics 334:3, pages 936-944.
Crossref
M. Obermeier, M. Yao, A. Khanna, B. Koplowitz, M. Zhu, W. Li, B. Komoroski, S. Kasichayanula, L. Discenza, W. Washburn, W. Meng, B. A. Ellsworth, J. M. Whaley & W. G. Humphreys. (2010) In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans. Drug Metabolism and Disposition 38:3, pages 405-414.
Crossref
Kathleen M. Giacomini, Shiew-Mei Huang, Donald J. Tweedie, Leslie Z. Benet, Kim L.R. Brouwer, Xiaoyan Chu, Amber Dahlin, Raymond Evers, Volker Fischer, Kathleen M. Hillgren, Keith A. Hoffmaster, Toshihisa Ishikawa, Dietrich Keppler, Richard B. Kim, Caroline A. Lee, Mikko Niemi, Joseph W. Polli, Yuicchi Sugiyama, Peter W. Swaan, Joseph A. Ware, Stephen H. Wright, Sook Wah Yee, Maciej J. Zamek-Gliszczynski & Lei Zhang. (2010) Membrane transporters in drug development. Nature Reviews Drug Discovery 9:3, pages 215-236.
Crossref
S-M Huang, L Zhang & K M Giacomini. (2010) The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA. Clinical Pharmacology & Therapeutics 87:1, pages 32-36.
Crossref
Kelly Bleasby, Xiaoyan Chu & Raymond Evers. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions 237 255 .
Hui-Po Wang & Chun-Li Wang. (2009) Biological Transporters as Targets for New Drug Design. Journal of Experimental & Clinical Medicine 1:1, pages 31-38.
Crossref
Manthena V. S. Varma, Bo Feng, R. Scott Obach, Matthew D. Troutman, Jonathan Chupka, Howard R. Miller & Ayman El-Kattan. (2009) Physicochemical Determinants of Human Renal Clearance. Journal of Medicinal Chemistry 52:15, pages 4844-4852.
Crossref
Li Xia, Mingyan Zhou, Thomas F. Kalhorn, Horace T. B. Ho & Joanne Wang. (2009) Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. American Journal of Physiology-Renal Physiology 296:6, pages F1307-F1313.
Crossref
Masahiro Tsuda, Tomohiro Terada, Miki Ueba, Tomoko Sato, Satohiro Masuda, Toshiya Katsura & Ken-ichi Inui. (2009) Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells. Journal of Pharmacology and Experimental Therapeutics 329:1, pages 185-191.
Crossref
Hongliang Cai, Arun K. Agrawal, David A. Putt, Muhammed Hashim, Anita Reddy, Joanne Brodfuehrer, Narayanan Surendran & Lawrence H. Lash. (2009) Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells. Toxicology 258:1, pages 56-63.
Crossref
Xin Ming, Wujian Ju, Huali Wu, Richard R. Tidwell, James E. Hall & Dhiren R. Thakker. (2009) Transport of Dicationic Drugs Pentamidine and Furamidine by Human Organic Cation Transporters. Drug Metabolism and Disposition 37:2, pages 424-430.
Crossref
Xiao-Yan Chu, Yuexia Liang, Xiaoxin Cai, Karla Cuevas-Licea, Ronda K. Rippley, Kelem Kassahun, Magang Shou, Matthew P. Braun, George A. Doss, M. Reza Anari & Raymond Evers. (2008) Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters. Pharmaceutical Research 26:2, pages 459-468.
Crossref
Paul D. Dobson & Douglas B. Kell. (2008) Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nature Reviews Drug Discovery 7:3, pages 205-220.
Crossref
M. Strolin Benedetti, R. Whomsley, F.-X. Mathy, P. Jacques, P. Espie & M. Canning. (2008) Stereoselective renal tubular secretion of levocetirizine and dextrocetirizine, the two enantiomers of the H 1 -antihistamine cetirizine . Fundamental & Clinical Pharmacology 22:1, pages 19-23.
Crossref
Marc E. De Broe & FranÇoise Roch-Ramel. 2008. Clinical Nephrotoxins. Clinical Nephrotoxins 43 71 .
Ivan Sabolić, Abdul R. Asif, Wolfgang E. Budach, Christoph Wanke, Andrew Bahn & Gerhard Burckhardt. (2007) Gender differences in kidney function. Pflügers Archiv - European Journal of Physiology 455:3, pages 397-429.
Crossref
Yoshitane Nozaki, Hiroyuki Kusuhara, Tsunenori Kondo, Masahiro Iwaki, Yoshiyuki Shiroyanagi, Hideki Nakayama, Shigeru Horita, Hayakazu Nakazawa, Teruo Okano & Yuichi Sugiyama. (2007) Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices. Journal of Pharmacology and Experimental Therapeutics 322:3, pages 1162-1170.
Crossref
Xiao-Yan Chu, Kelly Bleasby, Jocelyn Yabut, Xiaoxin Cai, Grace Hoyee Chan, Michael J. Hafey, Shiyao Xu, Arthur J. Bergman, Matthew P. Braun, Dennis C. Dean & Raymond Evers. (2007) Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein. Journal of Pharmacology and Experimental Therapeutics 321:2, pages 673-683.
Crossref
Li Xia, Karen Engel, Mingyan Zhou & Joanne Wang. (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. American Journal of Physiology-Renal Physiology 292:2, pages F682-F690.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.